VSTM (Verastem) Debt-to-Asset : 0.38 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VSTM Verastem Inc VSTM
15 GF Score
Price $5.69
! 7 Warning Signs
View Full Analysis

What is Verastem Debt-to-Asset?

Verastem VSTM -1.90% 15 Debt-to-Asset is 0.38 as of Mar. 2026. GuruFocus rates VSTM with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Verastem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $6.29 Mil. Verastem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $79.19 Mil. Verastem's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was $227.81 Mil. Verastem's debt to asset for the quarter that ended in Mar. 2026 was 0.38.

Verastem  (NAS:VSTM) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Verastem Debt-to-Asset Related Terms

Verastem Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Verastem's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verastem Debt-to-Asset Chart

Verastem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.29 0.28 0.42 0.35

Verastem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.43 0.51 0.35 0.38

VSTM vs PRME, ALT, FDMT: Debt-to-Asset Comparison

For the Biotechnology subindustry, Verastem's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verastem Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Verastem's Debt-to-Asset falls into.


VSTM
15GF Score
Verastem Inc VSTM
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Verastem Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Verastem's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(5.839 + 81.33) / 246.442
=0.35

Verastem's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(6.289 + 79.186) / 227.808
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.38 mean?
Verastem (VSTM) has a Debt-to-Asset of 0.38 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Verastem and its competitors.
Is Verastem's Debt-to-Asset too high?
Verastem's current Debt-to-Asset is 0.38. Overall, Verastem has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Verastem's Debt-to-Asset compare to PRME and ALT?
Verastem's Debt-to-Asset of 0.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Verastem and its competitors. Verastem's current Debt-to-Asset is 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verastem stock overvalued right now?
Verastem (VSTM) has a current Debt-to-Asset of 0.38. The current Debt-to-Asset is 0.38. Verastem's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Verastem (VSTM), the current Debt-to-Asset is 0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Verastem Business Description

Other Exchanges 0LOV:UK2VS:Germany
Address 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
15GF Score

Get the complete analysis for VSTM

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.69
Price